Financial Ratios

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE4088.90-45.05 (-1.09 %)
PREV CLOSE ( ) 4133.95
OPEN PRICE ( ) 4140.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18834
TODAY'S LOW / HIGH ( )4072.00 4140.05
52 WK LOW / HIGH ( )3101 4479.7
NSE4084.60-51.1 (-1.24 %)
PREV CLOSE( ) 4135.70
OPEN PRICE ( ) 4138.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4084.60 (2)
VOLUME 413095
TODAY'S LOW / HIGH( ) 4071.20 4140.60
52 WK LOW / HIGH ( )3101.6 4482.9
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)55.7840.1031.0658.5867.23
   CEPS(Rs)78.2262.5850.9347.0951.63
   DPS(Rs)32.0028.0022.0048.0035.00
   Book NAV/Share(Rs)224.32201.76190.75374.94356.30
   Tax Rate(%)27.6729.1933.3332.3816.71
Margin Ratios
   Core EBITDA Margin(%)36.1433.1831.4230.6033.45
   EBIT Margin(%)28.5425.4923.9024.8025.95
   Pre Tax Margin(%)26.3822.0120.1021.3620.85
   PAT Margin (%)19.0815.5813.4014.4417.37
   Cash Profit Margin (%)26.7624.3221.9723.2226.68
Performance Ratios
   ROA(%)14.9710.758.758.669.66
   ROE(%)26.1820.4316.4316.0220.41
   ROCE(%)27.8220.9618.1016.9416.30
   Asset Turnover(x)0.780.690.650.600.56
   Sales/Fixed Asset(x)0.750.690.700.690.66
   Working Capital/Sales(x)7.2311.5715.154.554.21
Efficiency Ratios
   Fixed Capital/Sales(x)1.331.461.431.451.51
   Receivable days69.0469.1976.0982.0485.05
   Inventory Days57.6766.3979.0898.6195.25
   Payable days137.91131.32117.53136.79163.65
Valuation Parameters
   PER(x)57.9864.8749.4923.8718.90
   PCE(x)41.3541.5630.1929.6924.61
   Price/Book(x)14.4212.898.067.467.13
   Yield(%)0.991.081.431.721.38
   EV/Net Sales(x)11.5610.707.347.507.34
   EV/Core EBITDA(x)31.0230.6222.1621.9520.49
   EV/EBIT(x)39.6441.1230.1129.7227.83
   EV/CE(x)11.048.985.124.544.03
   M Cap / Sales11.3110.326.767.026.67
Growth Ratio
   Net Sales Growth(%)13.4710.8914.134.524.57
   Core EBITDA Growth(%)21.0217.0210.50-0.227.25
   EBIT Growth(%)27.2118.4010.110.139.89
   PAT Growth(%)39.1329.076.05-12.8721.24
   EPS Growth(%)39.1329.07-46.97-12.8721.24
Financial Stability Ratios
   Total Debt/Equity(x)0.340.490.710.530.73
   Current Ratio(x)1.461.251.151.621.60
   Quick Ratio(x)0.950.730.690.900.88
   Interest Cover(x)13.237.326.307.215.09
   Total Debt/Mcap(x)0.020.040.090.070.10

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.